We demonstrated that a phase-sensitive HSQC pulse sequence with short scan times enables detection of 2-HG and 6-phosphogluconate/gluconate in live cancer cells as well as tumors ex vivo; this way, we can reliably identify tumors/cell lines that carry IDH-point mutations or PGD-homozygous deletions. The gene discussed is IDH1; the disease is cancer.